SLC7A5 and breast carcinoma: This was consistent when analysing protein expression, where SLC7A5+SLC3A2+ co-expression was shown to predict a high risk of distant metastasis and death from breast cancer (p < 0.05), but not recurrence (p = 0.25; Table 3).